SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of ...

Frederic L.W.V.J. Schaper, MD, PhD, director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at Brigham and Women’s Hospital and an instructor of neurology at Harvard Medical ...

On September 16, SK Biopharmaceuticals announced that it has obtained positive top-line results from a Phase 3 clinical trial evaluating cenobamate ...

Recurrent seizures are debilitating and can sometimes, be fatal. The onset and presentation of seizures vary significantly among epilepsy patients. Of more than 25 categories of seizure presentations ...

Epilepsy is a neurological (brain) condition involving recurrent seizures. There are many types of epilepsy that vary depending on where the seizures occur in the brain, how severe the seizures are, ...

NASHVILLE, Tennessee ―The retention rate for the antiseizure drug perampanel (Eisai Co, Ltd) is more than 70% for adult patients with epilepsy, new research shows. In early results from the PERPRISE ...

Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...

J Child Neurol. 2004;19(8):571-578. Patients with an isolated visually induced seizure in special circumstances, with or without a photoparoxysmal response on the EEG. This group comprises patients ...